- Max Healthcare reported net income of 3.19 billion rupees in the fourth quarter, marking a 27% increase from the previous year but missing the estimated target of 3.98 billion rupees.
- The company generated 19.1 billion rupees in revenue, a 35% increase year-over-year, which was below the expected revenue of 23.19 billion rupees.
- Total costs for the quarter rose by 37% from the previous year, reaching 15.5 billion rupees.
- Max Healthcare declared a dividend of 1.50 rupees per share.
- The company approved plans to add 100 beds at its Nagpur Multi-Speciality Hospital, with an investment of 1.18 billion rupees.
- Max Healthcare also approved the divestment of its stake in Sandhya Hydro Power.
- After the earnings announcement, Max Healthcare shares fell by 3% to 1,153 rupees, with 2.72 million shares traded.
- Analyst recommendations include 15 buy ratings, 4 hold ratings, and 4 sell ratings for Max Healthcare shares.
Max Healthcare Institute on Smartkarma
Analysts on Smartkarma, such as Tina Banerjee, are closely covering Max Healthcare Institute. According to research by Tina Banerjee, titled “Max Healthcare (MAXHEALTH IN): Multi-Pronged Expansion Strategy Augurs Well for Sustainable Growth,” Max Healthcare recently acquired Jaypee Healthcare, adding 700 beds in Q3FY25. The company is in the process of setting up a 500-bed hospital in Thane, Maharashtra. This expansion plan is expected to lead to a significant capacity ramp-up, with a projected increase of over 20% in FY26. The acquisition of Jaypee Healthcare has already contributed positively to Max Healthcare’s revenue and operating EBITDA, indicating a promising outlook for sustained growth.
A look at Max Healthcare Institute Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Max Healthcare Institute Limited, a chain of hospitals in India, appears to have a promising long-term outlook based on the Smartkarma Smart Scores. With high scores in Growth, Resilience, and Momentum, the company seems well-positioned for future success. The Growth and Resilience scores indicate potential for expansion and ability to weather challenges, while the strong Momentum score suggests positive market sentiment and performance.
The company’s focus on urology, oncology, orthopaedics, and other healthcare services, as described in its profile, aligns with the current trends in the healthcare industry. While the Value and Dividend scores are moderate, the overall outlook for Max Healthcare Institute appears optimistic, driven by its positive Growth, Resilience, and Momentum scores.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
